Hepatolenticular Degeneration

Wilson's disease, also called hepatolenticular degeneration or copper storage disease, is an inherited condition in which the body cannot get rid of excess copper. Normally the liver binds it to a protein called caeruloplasmin and passes any extra into the bile.

The disease is caused by faults in both copies of the ATP7B gene, one inherited from each parent. People with one faulty copy are carriers and have no symptoms. Without a working gene, copper collects in the liver, caeruloplasmin falls and free copper spills into the blood, harming the brain, kidneys and other organs.

Liver problems such as hepatitis, cirrhosis, jaundice, tiredness, abdominal pain and fluid in the abdomen often begin in childhood. Brain involvement tends to appear in the teens or twenties, with tremor, stiffness, trouble walking, speaking or swallowing, and mood or behaviour changes. Many patients have copper rings around the cornea (Kayser-Fleischer rings). Untreated, the disease is fatal, but early treatment lets most people live a fairly normal life.

Tests

Tests are used to diagnose the disease, judge its severity, tell patients apart from carriers, rule out other liver and nerve conditions and monitor treatment, as well as to check relatives. Samples must be protected from outside copper, abnormal results may be repeated, and carriers' results can overlap with those of people who have not yet developed symptoms.

Blood caeruloplasmin is usually low, although it can be normal in some patients, especially those with liver symptoms. Total blood copper is usually low but of limited use, while free (non-caeruloplasmin-bound) copper and 24-hour urine copper are usually high and help with diagnosis and monitoring. A liver biopsy measures the copper in liver tissue. Genetic testing of the ATP7B gene confirms the diagnosis and finds carriers in the family, but cannot predict how severe the illness will be. A full blood count, liver function tests, a slit-lamp eye examination and MRI or CT scans may also be used.

Treatment

Wilson's disease cannot be prevented or cured, but it can be well controlled. The aim is to remove excess copper, stop it building up again and protect the liver, brain and kidneys. People diagnosed before symptoms appear, such as brothers or sisters of a patient, are usually treated too, whereas carriers need genetic counselling rather than treatment.

Patients follow a low-copper diet and usually start on a chelating drug, D-penicillamine or trientine, which increases the copper passed in urine. Regular checks are needed because these drugs can lower blood cell counts and cause nausea, fever or skin problems. Once copper stores are normal, some people switch to zinc, which blocks copper absorption, and vitamin E may be advised. Treatment must continue for life, and severe cases may need a liver transplant.